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Liquid silicone has been used extensively as an injectable soft-tissue filler.1 It is inexpensive, available “off the shelf,” minimally antigenic, 
and likely noncarcinogenic, and it has demonstrated 
long-term in vivo stability.2 Injection is simple and 
allows for immediate, visible results with minimal 
downtime for patients. These properties make it a pop-
ular choice for soft-tissue augmentation in some parts 
of the world. However, the lack of well-documented 
controlled trials limits its usage, and there have been 
multiple reports describing the complications of sili-
cone injection such as cellulitis, abscess, ulceration, 
disfiguring scarring, and foreign body migration.3–14 
In this study, we report on a granulomatous reaction 
secondary to silicone injection for the buttock aug-
mentation performed in the Dominican Republic 
and review the available literature on this topic, par-
ticularly focusing on treatment modalities.
CASE	REPORT
The patient, a 54-year-old woman, presented to 
our emergency room with 4 days of erythema, indu-
ration, and pain in her bilateral buttocks (Fig. 1). Her 
medical history was significant for bilateral buttock 
augmentation, performed once on an outpatient, 
approximately 1 year before in the Dominican Repub-
lic. We contacted the practitioner who  performed the 
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Summary: Liquid silicone is inexpensive, minimally antigenic, and likely 
noncarcinogenic. Its simplicity of use has made it popular as a soft-tissue 
filler in some parts of the world for patients seeking rapid soft-tissue aug-
mentation of the face, breast, and buttocks. However, multiple reports de-
scribe the complications of silicone injections such as cellulitis, abscess, 
ulceration, and foreign body migration. We present an unusual compli-
cation of granulomatous reaction secondary to silicone injection for but-
tock augmentation, with a literature review of this entity and treatment 
options. Our patient was a 54-year-old woman who underwent bilateral 
buttock augmentation in the Dominican Republic using percutaneous in-
jection of liquid silicone. She presented to our facility 1 year after this pro-
cedure with pain and inflammation of both buttocks. She was diagnosed 
with multiple silicone granulomas. Her symptoms completely resolved with 
a 3-week course of minocycline. Granulomatous reactions to silicone may 
occur months to years after the silicone injection. The incidence of such 
complications may be increased when nonmedical-grade silicone is used, 
and hence, when these procedures are performed in developing countries. 
Tetracycline antibiotics, especially minocycline, may be used to achieve sus-
tained remission. (Plast Reconstr Surg Glob Open 2016;4:e624; doi: 10.1097/
GOX.0000000000000618; Published online 19 February 2016.)
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procedure by phone, but they did not have a record 
of the substance injected. The patient had a tempera-
ture of 101.2°F, and laboratory results showed a leu-
kocytosis of 12.2 thousands/microliter. Because of 
the concern about the possibility of infection (which 
we have seen commonly in similar patients), the 
patient was empirically started on vancomycin and 
ceftriaxone pending further studies. Magnetic reso-
nance imaging was performed, which demonstrated 
extensive edema of the gluteal subcutaneous tissue, 
numerous nodular foci likely representing injected 
foreign material, consistent with silicone, and no 
discrete drainable fluid. To rule out the infection 
and accurately diagnose the injected substance, we 
performed a deep tissue biopsy. This was sent for 
Gram stain and bacterial, fungal, and mycobacterial 
cultures—all of which returned negative. Pathology 
was consistent with a silicone granulomatous reaction 
associated with patchy acute inflammation (Fig. 2).
After review of the pathology, vancomycin and 
ceftriaxone were discontinued, and the patient was 
transitioned to twice daily 100 mg minocycline to 
treat this inflammatory reaction. She did not receive 
steroids. Her symptoms completely resolved within 
3 weeks, and minocycline was discontinued (Fig. 3). 
Given the diffuse and extensive nature of her sili-
cone injections and resolution of her symptoms with 
medical management, we decided against surgical 
debridement. She has not had any recurrence of her 
symptoms during 18-month follow-up.
DISCUSSION
Medical-grade silicone is a standardized sterile 
preparation with high purity and long shelf life.6,15 
Its use as a soft-tissue filler has been described using 
a microdroplet technique (0.01–0.03 mL droplets of 
silicone) in the deep dermal or subdermal plane at 
1- to 3-mm intervals with 4- to 6-week intervals 
between repeated injections.16 By using this tech-
nique, multiple authors have described satisfactory 
results.16,17 However, complications have been re-
ported. Injection of large volumes of silicone can re-
sult in tracking along tissue planes to distant sites.17,18 
Industrial or nonmedical silicone may be associated 
with high complication rates.19,20 Inexperienced 
practitioners may also be more apt to inject less judi-
ciously. Furthermore, it can be challenging to deter-
mine the technique and materials used when such 
procedures are performed in foreign countries and 
present in the United States with complications.
Erythema, edema, and textural changes that oc-
cur immediately after the procedure are generally 
self-limited. Serious complications include chronic 
cellulitis and abscess formation, ulceration, pneu-
monitis, cosmetic irregularities and asymmetries, 
Fig. 1. erythematous indurated lesions in bilateral buttocks 1 
year after silicone injections for buttock augmentation. Fig. 2. Biopsy from the buttock shows silicone granulomas 
consisting of variably sized vacuoles surrounded by scat-
tered lymphocytes, eosinophils, neutrophils, and plasma 
cells. Giant cells are often present but were not identified in 
this biopsy (hematoxylin and eosin stain, 40x).
Fig. 3. Resolution of symptoms after completion of 3-week 
minocycline therapy. scar on the right buttock is secondary 
to biopsy for pathology.
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perforation or injuries to critical structures, foreign 
body reactions, and migration of silicone. These 
can present even years after injection.3–7 Granulo-
matous reactions after silicone injection for buttock 
augmentation have only been reported in limited 
studies.8–14 A summary of available reports of silicone 
granuloma after liquid silicone injection for but-
tock augmentation is described in Table 1. The pe-
riod between procedure and symptoms ranges from 
5 months to 10 years. Almost all reported patients 
have been treated by unlicensed practitioners with 
an unknown grade of silicone.11 Most of the patients 
with this complication present with erythema, indu-
ration, and plaques (well-circumscribed, elevated, 
superficial, solid lesions) in the buttocks. Two of 
8 patients described in the literature underwent this 
procedure in Dominican Republic similar to our 
index patient.8,14
When patients present with an incomplete his-
tory, questionable circumstances, or unknown sur-
gery, an accurate diagnosis is a key step in directing 
appropriate treatment. We have been successful in 
achieving diagnoses with a combination of labora-
tory studies, imaging, and tissue pathology. Perhaps 
most important at the outset is to rule out a severe 
or atypical infection, many of which we have seen in 
cosmetic surgical patients returning from surgery in 
the developing world.
The treatment of silicone granulomas can be 
challenging, and a number of treatment modalities 
have been described with varying degrees of suc-
cess. Tetracycline antibiotics, mainly minocycline, 
have been reported to result in complete resolution 
of symptoms in multiple studies.21,22 This could be 
attributed to the inherent antiinflammatory and 
immune-modulating capacity of this drug. Other 
immunomodulating therapies, such as etanercept, 
have been described.8,23 Oral steroids may result in 
temporary resolution but seem to be prone to recur-
rence during tapering.21,24 Surgical excision may be 
considered if a granuloma is well circumscribed, but 
these injections are typically so extensive and diffuse 
that surgery can be complicated and disfiguring and 
complete silicone removal is often impossible.6
CONCLUSIONS
Granulomatous reactions to silicone may occur 
months to years after silicone injection for buttock 
augmentation. The incidence of such complications 
may be increased when nonmedical-grade silicone 
or poor technique is used. Given the abundance of 
well-studied alternative substances and the relative 
success of fat grafting in larger volume cases, we do 
not perform liquid silicone injections. The use of tet-
racycline antibiotics, especially minocycline, appears 
to be successful at achieving sustained remission.
Simon G. Talbot, MD 
Division of Plastic Surgery 
Department of Surgery
Brigham and Women’s Hospital 
Harvard Medical School 
75 Francis St., Boston, MA 02115 
E-mail: sgtalbot@partners.org
REFERENCES
 1. Loustau HD, Mayer HF, Catterino L. Dermolipectomy of 
the thighs and buttocks to solve a massive silicone oil in-
jection. Aesthetic Plast Surg. 2009;33:657–660.
Table 1. Disease and Treatment Characteristics of the Patients Diagnosed with Silicone Granulomas Secondary 
to Buttock Augmentation with Liquid Silicone Injection
Authors Age/Sex
Incubation		
Period Material/Practioner Symptoms Treatment
Pasternack et al8 47/F 10 y Medical grade/ 
nonprofessional (DR)
Erythema, swelling of 
anterior legs
Etanercept × 2 mo
Pasternack et al8 37/F 5 mo Not described Erythematous nodules  
and plaques in buttocks
Etanercept × 1 mo
Schwartzfarb et al9 40/F 9 mo Medical grade/ 
nonprofessional
Recurrent cellulitis of  
right lower extremity
Prednisone × 30 mg daily 
(tapered) + minocycline
Altmeyer et al10 38/F 1 y Unknown grade/ 
illegal practitioner
Erythematous plaques in 
bilateral gluteal cleft
Not discussed
Lopiccolo et al11 29/F 3 y Unknown grade/ 
illegal practitioner
Fever, chills, pain nodules 
in buttocks and  
posterior thighs
Minocycline 100 mg bid × 
4 wk + tetracycline 500 mg 
bid × 8 wk
Camuzard et al13 63/F 9 y Unknown grade/
unknown
Inflammatory plaques on 
buttocks, hypercalcemia
Prednisone 30 mg daily × 
3 wk (tapered)
Emer et al12 30/F Not described Unknown grade/
unknown
Edematous, indurated 
plaques and nodules  
of buttocks
Minocycline 100 mg bid
Paul et al14 47/F 9 mo to 2 y Unknown grade/not 
described (DR)
Erythematous indurated 
plaques on the left  
buttock
Doxycycline 100 mg × bid
bid, twice daily; F, female; DR, Dominican Republic.
4PRS Global Open • 2016
 2. Sobanko J, Scheinfeld N, Kriegel D. Liquid injectable 
silicone: should you implement it in your practice? Cosmet 
Dermatol. 2006;19:534–536.
 3. Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: 
cause of facial nodules, cellulitis, ulceration, and migra-
tion. Aesthetic Plast Surg. 1996;20:267–276.
 4. Ellenbogen R, Rubin L. Injectable fluid silicone therapy. 
Human morbidity and mortality. JAMA 1975;234:308–309.
 5. Gurvitis GE. Silicone pneumonitis after a cosmetic aug-
mentation procedure. N Engl J Med. 2006;354:211–212.
 6. Ficarra G, Mosqueda-Taylor A, Carlos R. Silicone granu-
loma of the facial tissues: a report of seven cases. Oral Surg 
Oral Med Oral Pathol Oral Radiol Endod. 2002;94:65–73.
 7. Arin MJ, Bäte J, Krieg T, et al. Silicone granuloma of 
the face treated with minocycline. J Am Acad Dermatol. 
2005;52(2 Suppl 1):53–56.
 8. Pasternack FR, Fox LP, Engler DE. Silicone granulomas 
treated with etanercept. Arch Dermatol. 2005;141:13–15.
 9. Schwartzfarb EM, Hametti JM, Romanelli P, et al. Foreign 
body granuloma formation secondary to silicone injec-
tion. Dermatol Online J. 2008;14:20.
 10. Altmeyer MD, Anderson LL, Wang AR. Silicone mi-
gration and granuloma formation. J Cosmet Dermatol. 
2009;8:92–97.
 11. Lopiccolo MC, Workman BJ, Chaffins ML, et al. Silicone 
granulomas after soft-tissue augmentation of the but-
tocks: a case report and review of management. Dermatol 
Surg. 2011;37:720–725.
 12. Emer J, Roberts D, Levy L, et al. Indurated plaques and 
nodules on the buttocks of a young healthy female. J Clin 
Aesthet Dermatol. 2013;6:46–49.
 13. Camuzard O, Dumas P, Foissac R, et al. Severe granulo-
matous reaction associated with hypercalcemia occurring 
after silicone soft tissue augmentation of the buttocks: a 
case report. Aesthetic Plast Surg. 2014;38:95–99.
 14. Paul S, Goyal A, Duncan LM, et al. Granulomatous reac-
tion to liquid injectable silicone for gluteal enhancement: 
review of management options and success of doxycy-
cline. Dermatol Ther. 2015;28:98–101.
 15. Selmanowitz VJ, Orentreich N. Medical-grade fluid 
silicone. A monographic review. J Dermatol Surg Oncol. 
1977;3:597–611.
 16. Narins RS, Beer K. Liquid injectable silicone: a review of 
its history, immunology, technical considerations, com-
plications, and potential. Plast Reconstr Surg. 2006;118(3 
Suppl):77S–84S.
 17. Duffy DM. Liquid silicone for soft tissue augmentation. 
Dermatol Surg. 2005;31(11 Pt 2):1530–1541.
 18. Orentreich DS. Liquid injectable silicone: techniques for 
soft tissue augmentation. Clin Plast Surg. 2000;27:595–612.
 19. Prather CL, Jones DH. Liquid injectable silicone for soft 
tissue augmentation. Dermatol Ther. 2006;19:159–168.
 20. Duffy DM. The silicone conundrum: a battle of anec-
dotes. Dermatol Surg. 2002;28:590–594.
 21. Arin MJ, Bäte J, Krieg T, et al. Silicone granuloma of 
the face treated with minocycline. J Am Acad Dermatol. 
2005;52(2 Suppl 1):53–56.
 22. Beer K. Delayed onset nodules from liquid injectable 
silicone: report of a case, evaluation of associated histo-
pathology and results of treatment with minocycline and 
celocoxib. J Drugs Dermatol. 2009;8:952–954.
 23. Desai AM, Browning J, Rosen T. Etanercept therapy for 
silicone granuloma. J Drugs Dermatol. 2006;5:894–896.
 24. Lemperle G, Gauthier-Hazan N. Foreign body granulo-
mas after all injectable dermal fillers: part 2. Treatment 
options. Plast Reconstr Surg. 2009;123:1864–1873.
